We have systematically expanded into multiple production facilities, broadened our capabilities and built a robust track record of global regulatory excellence. Investments in infrastructure enhancements continue for meeting evolving customer needs and driving long-term competitiveness.
Manufacturing Facilities
UNIT 1: Bonthapally, Hyderabad
Year
of Establishment
1986
API manufacturing
capacity
233 KL
Hydrogenation
Reaction Volume
7.4 KL
Solvent
Recovery System
100 KL/D
Cryogenic
Reaction Volume
25 KL
Regulatory
approvals
US FDA, EDQM,
CFDA, PMDA, et al.
UNIT 2: Pashamylaram, Hyderabad
Year
of Establishment
1994
API manufacturing
capacity
363 KL
Hydrogenation
Reaction Volume
6 KL
Solvent
Recovery System
20 KL/D
Cryogenic
Reaction Volume
15 KL
Regulatory
approvals
US FDA, EDQM, PMDA, ANVISA, et al.
UNIT 3: Gaddapotharam, Hyderabad
Year
of Establishment
2017
API manufacturing
capacity
305 KL
Hydrogenation
Reaction Volume
Facility creation under process
Solvent
Recovery System
50 KL/D
Cryogenic
Reaction Volume
15 KL
Regulatory
approvals
US FDA, EDQM, PMDA, ANVISA, et al.
Research & Development Centre
Development
Labs
15
15
hoods
60
Analytical
Labs
-
Dedicated kilo
Lab for
Scale up
Dedicated
labs for
Peptides
Separate
facility for
D2 analogues
Approvals
Company Overview
